Charles Schwab’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-33,282
| Closed | -$768K | – | 3549 |
|
|
2020
Q4 | $768K | Hold |
33,282
| – | – | ﹤0.01% | 2855 |
|
|
2020
Q3 | $339K | Sell |
33,282
-1,724
| -5% | -$17.6K | ﹤0.01% | 2991 |
|
|
2020
Q2 | $522K | Buy |
35,006
+5,290
| +18% | +$78.9K | ﹤0.01% | 2812 |
|
|
2020
Q1 | $363K | Buy |
29,716
+14,054
| +90% | +$172K | ﹤0.01% | 2817 |
|
|
2019
Q4 | $248K | Hold |
15,662
| – | – | ﹤0.01% | 3011 |
|
|
2019
Q3 | $193K | Buy |
+15,662
| New | +$193K | ﹤0.01% | 3044 |
|